Cumulative incidence of, risk factors for, and outcome of dermatological complications of anti-TNF therapy in inflammatory bowel disease: a 14-year experience.

Estelle Fréling,Cédric Baumann,J.-F. Cuny,Marc-André Bigard,Schmutz Jl,Annick Barbaud,Laurent Peyrin-Biroulet

Cumulative incidence of, risk factors for, and outcome of dermatological complications of anti-TNF therapy in inflammatory bowel disease: a 14-year experience.

2015

Estelle Fréling
Cédric Baumann
J.-F. Cuny
Marc-André Bigard
Schmutz Jl
Annick Barbaud
Laurent Peyrin-Biroulet

Cumulative Incidence of, Risk Factors for, and Outcome of Dermatological Complications of Anti-TNF Therapy in Inflammatory Bowel Disease: A 14-Year Experience

Keywords:

General surgery
Psoriasis
Proportional hazards model
Tumor necrosis factor alpha
Young adult
Inflammatory bowel disease
Retrospective cohort study
Diabetes mellitus
Surgery
Cumulative incidence
Internal medicine
Medicine
Adalimumab
Infliximab

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations